Alnylam Pharmaceuticals
ALNY
#628
Rank
$32.22 B
Marketcap
$249.86
Share price
0.43%
Change (1 day)
51.19%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company